GAL-021

CAS No. 1380341-99-0

GAL-021 ( GAL021;GAL 021 )

Catalog No. M11573 CAS No. 1380341-99-0

A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 81 In Stock
10MG 122 In Stock
25MG 228 In Stock
50MG 357 In Stock
100MG 530 In Stock
500MG 1152 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GAL-021
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.
  • Description
    A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker; reverses opioid-induced respiratory depression without compromising opioid analgesia in vivo. Respiratory insufficiencyOther Indication Phase 1 Clinical
  • Synonyms
    GAL021;GAL 021
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    BKCa-channel
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    1380341-99-0
  • Formula Weight
    254.33
  • Molecular Formula
    C11H22N6O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 30 mg/mL
  • SMILES
    CCCNC1=NC(N(OC)C)=NC(NCCC)=N1
  • Chemical Name
    1,3,5-Triazine-2,4,6-triamine, N2-methoxy-N2-methyl-N4,N6-dipropyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. McLeod JF, et al. Br J Anaesth. 2014 Nov;113(5):875-83.
2. Golder FJ, et al. Anesthesiology. 2015 Nov;123(5):1093-104.
3. Dallas ML, et al. Adv Exp Med Biol. 2015;860:361-70.
4. Roozekrans M, et al. Anesthesiology. 2014 Sep;121(3):459-68.
molnova catalog
related products
  • Retigabine dihydroch...

    Retigabine dihydrochloride is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment-experienced adult patients.?The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.In differentiated PC12 cells, retigabine enhanced a linopirdine-sensitive current.?

  • Gliquidone

    Gliquidone is an anti-diabetic drug in the sulfonylurea class. It is used in the treatment of diabetes mellitus type 2.

  • JNJ 303

    JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).